company background image
M logo

Med Life BVB:M Stock Report

Last Price

RON 5.85

Market Cap

RON 3.2b

7D

-4.1%

1Y

44.8%

Updated

18 Dec, 2024

Data

Company Financials +

Med Life S.A.

BVB:M Stock Report

Market Cap: RON 3.2b

M Stock Overview

A private healthcare provider, offers healthcare services in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures. More details

M fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance2/6
Financial Health1/6
Dividends0/6

Rewards

Trading at 58.7% below our estimate of its fair value

Earnings are forecast to grow 92.89% per year

Became profitable this year

Risk Analysis

Interest payments are not well covered by earnings


My Notes

Capture your thoughts, links and company narrative

Med Life S.A. Competitors

Universal Vision Biotechnology

TPEX:3218

NT$17.5b

Zhongjin Irradiation

SZSE:300962

CN¥4.7b

Jinxin Fertility Group

SEHK:1951

HK$8.0b

Gushengtang Holdings

SEHK:2273

HK$7.7b

Price History & Performance

Summary of share price highs, lows and changes for Med Life
Historical stock prices
Current Share PriceRON 5.85
52 Week HighRON 6.25
52 Week LowRON 3.83
Beta0.78
1 Month Change-4.10%
3 Month Change-1.52%
1 Year Change44.80%
3 Year Change2.18%
5 Year Change329.36%
Change since IPO440.00%

Recent News & Updates

Recent updates

Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

Aug 06
Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Jun 08
The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Is Med Life (BVB:M) A Risky Investment?

Apr 05
Is Med Life (BVB:M) A Risky Investment?

Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Jul 05
Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Is Med Life (BVB:M) A Risky Investment?

Jan 06
Is Med Life (BVB:M) A Risky Investment?

Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

Dec 06
Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Sep 27
We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Returns Are Gaining Momentum At Med Life (BVB:M)

May 05
Returns Are Gaining Momentum At Med Life (BVB:M)

Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Mar 01
Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Jan 22
Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Aug 31
Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Med Life's (BVB:M) Returns On Capital Are Heading Higher

Jun 10
Med Life's (BVB:M) Returns On Capital Are Heading Higher

Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

May 26
Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

May 12
Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Apr 12
Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Mar 16
Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Mar 04
Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Feb 20
Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Feb 07
Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Jan 25
Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Jan 08
Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Dec 23
Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

Dec 08
Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

The Trends At Med Life (BVB:M) That You Should Know About

Nov 24
The Trends At Med Life (BVB:M) That You Should Know About

Shareholder Returns

MRO HealthcareRO Market
7D-4.1%-0.5%-0.2%
1Y44.8%5.1%7.2%

Return vs Industry: M exceeded the RO Healthcare industry which returned 5.1% over the past year.

Return vs Market: M exceeded the RO Market which returned 7.2% over the past year.

Price Volatility

Is M's price volatile compared to industry and market?
M volatility
M Average Weekly Movement4.2%
Healthcare Industry Average Movement4.2%
Market Average Movement4.4%
10% most volatile stocks in RO Market12.4%
10% least volatile stocks in RO Market2.9%

Stable Share Price: M has not had significant price volatility in the past 3 months compared to the RO market.

Volatility Over Time: M's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19966,997Mihail Marcuwww.medlife.ro

Med Life S.A., a private healthcare provider, offers healthcare services in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures. Its Corporate business line offers health prevention packages to corporate clients, which cover regular check-ups and access to diagnostic services. The company's Clinics business line provides services through hyper clinics for clinical examinations and imaging services, as well as clinics that offer a range of treatments from general practitioner services to specialists, as well as day inpatient services.

Med Life S.A. Fundamentals Summary

How do Med Life's earnings and revenue compare to its market cap?
M fundamental statistics
Market capRON 3.15b
Earnings (TTM)RON 21.71m
Revenue (TTM)RON 2.57b

143.1x

P/E Ratio

1.2x

P/S Ratio

Is M overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M income statement (TTM)
RevenueRON 2.57b
Cost of RevenueRON 1.31b
Gross ProfitRON 1.26b
Other ExpensesRON 1.24b
EarningsRON 21.71m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.041
Gross Margin48.99%
Net Profit Margin0.85%
Debt/Equity Ratio249.2%

How did M perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 17:28
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Med Life S.A. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caius RapanuErste Group Bank AG
Catalin DiaconuRaiffeisen Bank International AG - Institutional Equity
Cristian PopescuSwiss Capital SA